# Prima-Temp

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/prima-temp

- Industry: Medical Devices & Equipment
- Headquarters: Boulder, US
- Website: www.prima-temp.com
- Total disclosed funding: $3M
- Latest round: Series C (Feb 8, 2016)
- Investors on record: 2

## About

Prima-Temp, Inc. specializes in women's health technology, offering innovative solutions for fertility management through its advanced Priya Personal Fertility System, which enhances ovulation prediction using continuous core body temperature monitoring.Founded in 2010 in Boulder, US, Prima-Temp, Inc. focuses on developing technology for women's health. The company has raised a total of USD 5.43 mn through various funding rounds, with its latest round occurring on October 13, 2017. The founder, Wade Webster, has previously been involved in other ventures, although specific details are not provided.Prima-Temp's primary product offering is the Priya Personal Fertility System, which leverages continuous core body temperature (CCBT) technology to enhance ovulation prediction and provide clinical diagnostic support for women. By capturing temperature variations influenced by hormonal changes, meals, and sleep, the Priya system generates an in-depth physiological profile that empowers users to make informed healthcare decisions. The product is particularly beneficial for women managing fertility, as it provides a convenient and precise method for tracking ovulation. Furthermore, Prima-Temp is actively researching additional applications of its CCBT technology to address metabolic disorders and menopause. The company’s services extend to an extensive community of users, particularly in the United States and other developed markets where women's health and fertility management solutions are in high demand.Prima-Temp generates revenue primarily through direct-to-consumer sales of its flagship product, the Priya Personal Fertility System, alongside potential subscription models related to ongoing fertility management services. Transactions typically occur at the point of sale, where consumers purchase the device directly, which may include access to an integrated app for tracking and analysis. The company may also explore partnerships with healthcare providers and telemedicine platforms to broaden its service reach and enhance revenue streams. By focusing on women’s health, particularly fertility, the company positions itself to capture a growing market segment, supported by its advanced technology and community engagement strategies.Looking ahead, Prima-Temp plans to expand its product line with new offerings designed to support women's health, although specific details regarding new products or release dates are not provided. The company is targeting growth in new markets and geographic regions, particularly focusing on developed markets where demand for women's health solutions is increasing. The recent funding of USD 5.43 mn raised in October 2017 will be utilized to support these initiatives, allowing Prima-Temp to enhance its technological capabilities and broaden its outreach in the fertility management sector.

## Funding rounds

- Series C, Feb 8, 2016, $1.6M — Green Park & Golf Ventures
- Series A, Jun 1, 2014, $1.4M — Astia Angels

## Investors

- Astia Angels (https://capitalatlas.ai/funds/astia-angels) — Series A
- Green Park & Golf Ventures (https://capitalatlas.ai/funds/green-park-golf-ventures) — Series C